InterpaceBiosciences_New Logo.png
Interpace Biosciences Announces Record Third Quarter 2023 Financial and Business Results
08 nov. 2023 15h29 HE | Interpace Biosciences, Inc.
 ●Q3 Revenue of $9.1 million; an 11% increase year-over-year ●Q3 Test volume up 11% year-over-year ●Q3 Reimbursement improvement up 11% year-over-year, driven by additional commercial contracts and...
Logo.png
Interpace to Host Conference Call and Webcast to Discuss Third Quarter 2019 Financial Results on Wednesday, November 13, 2019
12 nov. 2019 06h55 HE | Interpace Diagnostics Group, Inc.
PARSIPPANY, NJ, Nov. 12, 2019 (GLOBE NEWSWIRE) -- Interpace (IDXG) announced today that it will report its third quarter 2019 financial results on Wednesday, November 13, 2019 at 4:30 p.m. ET....
Logo.png
Interpace to Present Data at the ATA Annual Meeting
29 oct. 2019 06h55 HE | Interpace Diagnostics Group, Inc.
PARSIPPANY, NJ, Oct. 29, 2019 (GLOBE NEWSWIRE) -- Interpace (IDXG) announced today that it will be presenting new data on the performance of its molecular thyroid products at the upcoming 89th...